Sun, Aug 18 1:46pm


Seattle Genetics Inc [SGEN]
$79.20 2.49 (3.25%)

SGEN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 12.81 Billion
SGEN Description

Seattle Genetics is a biotech firm focused on the development of monoclonal antibody-based therapies. The company's lead product, Adcetris, has received approval for advanced frontline, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. The company has several other early-stage programs in trials. Seattle Genetics also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies.


Visit Website

SGEN Earnings

EPS -0.49 P/E Ratio 0.00
Previous Earnings Thu, Apr 25, 2019
Latest Earnings Tue, Jul 16, 2019 (33 days ago) +23.77%

SGEN Dividend

Yield --
Ex-Date --
Pay Date --
History --

SGEN Charts

$52.25
1 Year
$84.37
Dec 21, 2018
Oct 3, 2018



Symbol Price Day % YTD %
SGEN $79.20 3.25% 37.76%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy